Douthwaite S et al. |
Macrolide-ketolide inhibition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA. |
2000 |
Mol. Microbiol. |
pmid:10760175
|
Najib MM et al. |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia. |
2000 |
Pharmacotherapy |
pmid:10772376
|
Van Oijen AH et al. |
Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930892
|
Hurenkamp GJ et al. |
Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930901
|
Lai KC et al. |
Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930902
|
Pilotto A et al. |
Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930903
|
Kihira K et al. |
Rabeprazole, amoxycillin and low- or high-dose clarithromycin for cure of Helicobacter pylori infection. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930904
|
Kamada T et al. |
Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of helicobacter pylori in smokers. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930905
|
Savarino V et al. |
OAM for cure of Helicobacter pylori infection. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930908
|
Amayasu H et al. |
Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. |
2000 |
Ann. Allergy Asthma Immunol. |
pmid:10875487
|
Maggiolo F et al. |
In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus. |
2000 |
J Chemother |
pmid:10877512
|
Hammerschlag MR and Roblin PM |
Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae. |
2000 |
Int. J. Antimicrob. Agents |
pmid:10854812
|
Hirschl AM et al. |
In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858365
|
Lamouliatte H et al. |
[Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers]. |
2000 |
Gastroenterol. Clin. Biol. |
pmid:10891736
|
Ives TJ et al. |
In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofluorescent antibody analysis of infected vero cell monolayers. |
2000 |
J. Antimicrob. Chemother. |
pmid:10702548
|
Schweeger I et al. |
Successful eradication of Helicobacter pylori as determined by ((13))C-urea breath test does not alter fibrinogen and acute phase response markers. |
2000 |
Thromb. Res. |
pmid:10704650
|
Parola D et al. |
[Efficacy and safety of clarithromycin in the treatment of community-acquired pneumonia]. |
2000 |
Recenti Prog Med |
pmid:10705778
|
Fonquernie L et al. |
[Pseudotumoral abdominal granuloma concomitant with immune reconstitution after antiretroviral treatment]. |
2000 |
Presse Med |
pmid:10705894
|
Raderer M et al. |
Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. |
2000 |
Gut |
pmid:10601069
|
Tran JQ et al. |
Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables. |
2000 |
J. Antimicrob. Chemother. |
pmid:10719007
|
Numazaki K et al. |
Therapeutic effect of clarithromycin for respiratory-tract infections in children caused by Chlamydia pneumoniae. Research Group of Sapporo for Pediatric Chlamydial Infections. |
2000 |
Int. J. Antimicrob. Agents |
pmid:10724028
|
Gomollón F et al. |
[Does eliminating Helicobacter pylori mean the healing of the duodenal ulcer? The results of a prospective study in Spain]. |
2000 |
Gastroenterol Hepatol |
pmid:10726384
|
Fernández-Roblas R et al. |
In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10602744
|
Jung R et al. |
Postantibiotic effects and bactericidal activities of clarithromycin-14-hydroxy-clarithromycin, versus those of amoxicillin-clavulanate, against anaerobes. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10681358
|
Abe S et al. |
Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. |
2000 |
Am. J. Respir. Cell Mol. Biol. |
pmid:10615065
|
Sugimoto M et al. |
Prevention of hemorrhage from intradiverticular ulcer in the duodenum by Helicobacter pylori eradication. |
2000 |
Am. J. Gastroenterol. |
pmid:10685780
|
Zuckerman JM |
The newer macrolides: azithromycin and clarithromycin. |
2000 |
Infect. Dis. Clin. North Am. |
pmid:10829265
|
Bortolotti M et al. |
Effect of clarithromycin on esophageal motility. |
2000 |
Dis. Esophagus |
pmid:11206638
|
Hoshiya S et al. |
Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan. |
2000 |
J. Gastroenterol. |
pmid:10632534
|
Fujioka T |
Clarithromycin resistance in Helicobacter pylori: implications for therapy. |
2000 |
J. Gastroenterol. |
pmid:10632546
|
Iakovlev VP et al. |
[Macrolide antibiotic clarithromycin (Klabax) in treatment of community-acquired respiratory tract infections]. |
2000 |
Antibiot. Khimioter. |
pmid:11210297
|
Bardhan KD et al. |
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632646
|
Sazykin IuO et al. |
[Clarithromycin and tumor chemotherapy]. |
2000 |
Antibiot. Khimioter. |
pmid:11210301
|
Cammarota G et al. |
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632648
|
Gasbarrini A et al. |
Efficacy of a multistep strategy for Helicobacter pylori eradication. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632649
|
Chan FK et al. |
Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632651
|
Rhee CS et al. |
Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis. |
2000 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10823478
|
Sato K et al. |
Antimicrobial activities of levofloxacin, clarithromycin, and KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium complex replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines. |
2000 |
Int. J. Antimicrob. Agents |
pmid:11185410
|
Paton R et al. |
Susceptibility testing of Haemophilus influenzae to clarithromycin. |
2000 |
J. Antimicrob. Chemother. |
pmid:10747833
|
Fujimura S et al. |
Clarithromycin-susceptible Helicobacter pylori with mutation in 23S rRNA gene by PCR-RFLP method. |
2000 |
J. Gastroenterol. |
pmid:10777165
|
Abisheganaden JA et al. |
Effect of clarithromycin on experimental rhinovirus-16 colds: a randomized, double-blind, controlled trial. |
2000 |
Am. J. Med. |
pmid:10781777
|
Kaushik SP and Vu C |
Helicobacter pylori eradication with lansoprazole, amoxycillin and clarithromycin: testing an ideal regimen in a multicultural south east Asian population and examining factors potentially influencing eradication. |
2000 |
Aust N Z J Med |
pmid:10833116
|
Waites K et al. |
Use of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children. |
2000 |
J. Clin. Microbiol. |
pmid:10790089
|
Ianaro A et al. |
Anti-inflammatory activity of macrolide antibiotics. |
2000 |
J. Pharmacol. Exp. Ther. |
pmid:10604943
|
Calvet X et al. |
A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10792124
|
Shimizu T et al. |
Successful treatment using clarithromycin for a cutaneous lesion caused by Mycobacterium szulgai. |
2000 |
Br. J. Dermatol. |
pmid:10792258
|
Vernet Vernet M et al. |
[Analysis of indications and diagnosis of the gastroscopies requested by primary care physicians]. |
2000 |
Aten Primaria |
pmid:10795440
|
Shashidhar H et al. |
A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection. |
2000 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:10749411
|
Joosen EA et al. |
Costs and benefits of a test-and-treat strategy in Helicobacter pylori-infected subjects: a prospective intervention study in general practice. |
2000 |
Eur J Gastroenterol Hepatol |
pmid:10750653
|
Woo PC et al. |
Clarithromycin attenuates cyclophosphamide-induced mucositis in mice. |
2000 |
Pharmacol. Res. |
pmid:10753551
|
Frank F et al. |
Helicobacter pylori infection in recurrent abdominal pain. |
2000 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:11045841
|
Giannini E et al. |
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens. |
2000 |
Am. J. Gastroenterol. |
pmid:11051345
|
Herr H and You CH |
Relationship between Helicobacter pylori and rosacea: it may be a myth. |
2000 |
J. Korean Med. Sci. |
pmid:11068993
|
Isomoto H et al. |
5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11121910
|
Canducci F et al. |
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11121911
|
Toracchio S et al. |
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11121913
|
Bañuls J et al. |
Mycobacterium chelonae infection resistant to clarithromycin in a patient with dermatomyositis. |
2000 |
Br. J. Dermatol. |
pmid:11122063
|
Krebs T et al. |
Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukaemia. |
2000 |
J. Intern. Med. |
pmid:11086646
|
Witthaut J and Möhlen S |
[Chronic paronychia and synovialitis of extensor tendons due to Mycobacterium marinum. Is diagnosis or treatment the problem?]. |
2000 |
Handchir Mikrochir Plast Chir |
pmid:11103693
|
Lerro P et al. |
CagA seropositivity and the severity of Helicobacter pylori infection in dyspeptic children. |
2000 |
Acta Paediatr. |
pmid:11106041
|
Fock KM |
Clarithromycin resistance in Helicobacter pylori infection: does it matter? |
2000 |
J. Gastroenterol. Hepatol. |
pmid:11106085
|
Rea TH |
Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy. |
2000 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:11036492
|
Bhasin DK et al. |
Drug resistance in Helicobacter pylori infection. |
2000 |
Indian J Gastroenterol |
pmid:11060974
|
Vcev A et al. |
Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10632647
|
Badyal DK and Garg SK |
Effect of clarithromycin on the pharmacokinetics of carbamazepine in rhesus monkeys. |
2000 |
Methods Find Exp Clin Pharmacol |
pmid:11196346
|
Drinkard CR et al. |
Postmarketing surveillance of medications and pregnancy outcomes: clarithromycin and birth malformations. |
2000 |
Pharmacoepidemiol Drug Saf |
pmid:11338912
|
Catalano F et al. |
Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11012478
|
Gomollón F et al. |
Third line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11012479
|
Nomura H et al. |
A short-term eradication therapy for Helicobacter pylori acute gastritis. |
2000 |
J. Gastroenterol. Hepatol. |
pmid:11197046
|
Yanagihara K et al. |
Intrapulmonary concentrations of inflammatory cytokines in a mouse model of chronic respiratory infection caused by Pseudomonas aeruginosa. |
2000 |
Clin. Exp. Immunol. |
pmid:11012620
|
Koizumi T et al. |
[Pulmonary Mycobacterium gordonae infection treated with clarithromycin]. |
2000 |
Kekkaku |
pmid:11201139
|
Alter P et al. |
[Impediment of cellular immune response under treatment with ticlopidine in a patient with Staphylococcus aureus endocarditis]. |
2000 |
Z Kardiol |
pmid:11013974
|
Vergassola R et al. |
[Chlamydia pneumoniae and myocardial infarction (CLINF). Preliminary randomized controlled study with clarithromycin. CLAINF protocol]. |
2000 |
Minerva Cardioangiol |
pmid:11253326
|
Kurowski K et al. |
Clarithromycin-induced alterations in vaginal flora. |
2000 |
Am J Ther |
pmid:11317173
|
Shivkumar K |
Images in cardiovascular medicine. Labile repolarization from "cell to bedside". |
2000 |
Circulation |
pmid:10942753
|
Daudén E et al. |
Helicobacter pylori and idiopathic chronic urticaria. |
2000 |
Int. J. Dermatol. |
pmid:10944090
|
Khor CJ et al. |
Recurrence of Helicobacter pylori infection and duodenal ulcer relapse, following successful eradication in an urban east Asian population. |
2000 |
Singapore Med J |
pmid:11256345
|
Sato K and Ebe T |
[A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease]. |
2000 |
Kekkaku |
pmid:10944891
|
Katz VL et al. |
Mycobacterium chelonae sepsis associated with long-term use of an intravenous catheter for treatment of hyperemesis gravidarum. A case report. |
2000 |
J Reprod Med |
pmid:10948471
|
Mayhew BS et al. |
An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation. |
2000 |
Drug Metab. Dispos. |
pmid:10950845
|
Gücüyener K et al. |
Methyl-prednisolone in neurologic complications of Mycoplasma pneumonia. |
2000 |
Indian J Pediatr |
pmid:10932970
|
Brophy DF et al. |
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10722500
|
Kohri K et al. |
Macrolide antibiotics inhibit nitric oxide generation by rat pulmonary alveolar macrophages. |
2000 |
Eur. Respir. J. |
pmid:10678622
|
Mordi MN et al. |
Acid-catalyzed degradation of clarithromycin and erythromycin B: a comparative study using NMR spectroscopy. |
2000 |
J. Med. Chem. |
pmid:10669574
|
Matsuoka M et al. |
A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin. |
2000 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:11332288
|
Makristathis A et al. |
Two enzyme immunoassays and PCR for detection of Helicobacter pylori in stool specimens from pediatric patients before and after eradication therapy. |
2000 |
J. Clin. Microbiol. |
pmid:11015388
|
Wolfe J et al. |
Mycobacterium branderi from both a hand infection and a case of pulmonary disease. |
2000 |
J. Clin. Microbiol. |
pmid:11015432
|
Umegaki N et al. |
Clarithromycin-resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Japan. |
2000 |
J. Gastroenterol. Hepatol. |
pmid:11022832
|
Goh K et al. |
Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients. |
2000 |
J. Gastroenterol. Hepatol. |
pmid:11022833
|
Ishigo S et al. |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture]. |
2000 |
Jpn J Antibiot |
pmid:11234221
|
Colin AA |
Eradication of mycobacterium abscessus in a chronically infected patient with cystic fibrosis. |
2000 |
Pediatr. Pulmonol. |
pmid:10973047
|
Yamashita H et al. |
When can complete regression of low-grade gastric lymphoma of mucosa-associated lymphoid tissue be predicted after helicobacter pylori eradication? |
2000 |
Histopathology |
pmid:10931236
|
Bortolotti M et al. |
Dose-related stimulatory effect of clarithromycin on interdigestive gastroduodenal motility. |
2000 |
Digestion |
pmid:10899723
|
Maggi-Solcà N et al. |
Prevalence of Helicobacter pylori resistant strains in the southern part of Switzerland. |
2000 |
Clin. Microbiol. Infect. |
pmid:11168035
|
Adamsson I et al. |
The use of AP-PCR and flaA-RFLP typing to investigate treatment failure in Helicobacter pylori infection. |
2000 |
Clin. Microbiol. Infect. |
pmid:11168124
|
Moayyedi P et al. |
Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group. |
2000 |
Lancet |
pmid:10905240
|
Sicilia B et al. |
[High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy]. |
2000 |
Med Clin (Barc) |
pmid:11141412
|
Miwi H et al. |
Comparison of the efficacy of 400mg and 800mg of clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection in a Japanese population. |
2000 |
J. Gastroenterol. |
pmid:10905362
|
Pilotto A et al. |
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study. |
2000 |
Dig Liver Dis |
pmid:11142574
|
Yanagihara K et al. |
Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation. |
2000 |
J. Antimicrob. Chemother. |
pmid:10882691
|